Knights Of Columbus Asset Advisors LLC Haemonetics Corp Transaction History

Knights Of Columbus Asset Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$81.24 - $97.37 $1.56 Million - $1.87 Million	-19,171 Reduced 47.52%	21,168 $1.75 Million
Q1 2024 May 10, 2024	SELL	$71.24 - $85.35 $300,775 - $360,347	-4,222 Reduced 9.47%	40,339 $3.44 Million
Q4 2023 Jan 31, 2024	BUY	$80.59 - $92.61 $2.78 Million - $3.2 Million	34,556 Added 345.39%	44,561 $3.81 Million
Q3 2023 Nov 01, 2023	BUY	$82.56 - $93.49 $10,567 - $11,966	128 Added 1.3%	10,005 $896,000
Q1 2023 May 01, 2023	BUY	$72.75 - $90.6 $718,551 - $894,856	9,877 New	9,877 $817,000
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $1.62 Million - $2.26 Million	-19,015 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $1.41 Million - $2.32 Million	19,015 New	19,015 $1.9 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.